Bromide

Bromide

SCHEMBL6743444

Cn1c(COCc2nc3ccccc3n2C)nc2ccccc21.[Br-].[Br-].[Ni+2]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.67
NPC1 O15118 9/20 0.67
SMN1; SMN2 Q16637 4/20 0.57
MAPT P10636 3/20 0.57
TP53 P04637 2/20 0.57
LMNA P02545 2/20 0.55
KMT2A Q03164 2/20 0.55
KDM4E B2RXH2 1/20 0.54
POLB P06746 1/20 0.54
PKM P14618 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957065 0.96 RAB9A (0.71) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL8278826 0.88 RAB9A (0.65) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL12362460 0.84 RAB9A (0.69) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL2247920 0.80 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL1059693 0.80 RAB9A (0.64) RAB9ANPC1SMN1; SMN2MAPTLMNA
SCHEMBL4146754 0.79 RAB9A (0.58) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL757031 0.78 RAB9A (0.62) RAB9ANPC1SMN1; SMN2MAPTLMNA
SCHEMBL30037937 0.78 RAB9A (0.62) RAB9ANPC1SMN1; SMN2MAPTLMNA
SCHEMBL15800270 0.78 RAB9A (0.60) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL285358 0.77 RAB9A (0.60) RAB9ANPC1SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689928-B2 PREPARED IN SITU FROM A NICKEL, PALLADIUM OR PLATIINUM COMPOUND AND A NITROGEN-CONTAINING LIGAND; OLIGOMERIZING OLEFIN MONOMERS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2004-02-10 US disclosed